Scholars Central

Conference abstractPublished 5 Dec 2015

Application of Molecular Medicine towards personalized treatment in Oncology

Authors: Godfrey Grech

University of Malta, Malta

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Molecular medicine evolved rapidly in the past decade, focusing on genetics and cellular mechanisms of disease, providing knowledge on (1) causative genes in monogenic diseases and syndromes, as well as susceptibility genes that work in concert with other genetic and environmental factors to elicit the disease; and (2) deregulated mechanisms within specific subtypes of disease, to classify patients molecularly and identify potential or already known therapeutic targets. In oncology, research and its evidence-based scientific outcomes evolved from the lab bench to bedside, implementing the use of biomarkers as classifiers of therapeutic groups; characterization of syndromes with high risk for specific disease, hence providing the opportunity for risk reduction strategies; predictive biomarkers to guide treatment type, dose and toxicity; and prognostic biomarkers to define specific clinical outcomes. Preventive genetics plays a role in defining specific genetic disorders through population screening for carriers of rare, fully penetrant alleles that cause monogenic diseases, and genotyping of susceptibility genes within families with high risk of developing a specific disease, providing the basis of Public Health Genetics. Predictive genetics deals with the efficacy and toxicity of drugs in individuals. The predictive value of biomarkers will be discussed in the context of clinical decision making for a variety of tumor types, including the use of irinotecan, tamoxifen, fluorouracil, imatinib, and Herceptin. Breast cancer will be discussed as a model of the use of molecular markers; the use of technology to bridge the gap between laboratory and clinical setting; and the need of novel targets to overcome targeted therapy resistance. Uptake of Molecular Medicine in the Health Care System requires continuous education of the Healthcare professionals and proper dissemination of information within the healthcare system. The current gaps and future recommendations will be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Godfrey Grech”